SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 219 filers reported holding SEATTLE GENETICS INC in Q2 2016. The put-call ratio across all filers is 0.60 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $57,000 | +216.7% | 290 | +81.2% | 0.02% | +212.5% |
Q4 2019 | $18,000 | +28.6% | 160 | 0.0% | 0.01% | +14.3% |
Q3 2019 | $14,000 | +7.7% | 160 | -15.8% | 0.01% | 0.0% |
Q2 2019 | $13,000 | -7.1% | 190 | 0.0% | 0.01% | 0.0% |
Q1 2019 | $14,000 | +7.7% | 190 | 0.0% | 0.01% | 0.0% |
Q4 2018 | $13,000 | -18.8% | 190 | -9.5% | 0.01% | -12.5% |
Q3 2018 | $16,000 | +14.3% | 210 | 0.0% | 0.01% | 0.0% |
Q2 2018 | $14,000 | +16.7% | 210 | -8.7% | 0.01% | +14.3% |
Q1 2018 | $12,000 | 0.0% | 230 | 0.0% | 0.01% | 0.0% |
Q4 2017 | $12,000 | -99.9% | 230 | -32.4% | 0.01% | -41.7% |
Q3 2017 | $18,499,000 | +5.2% | 340 | 0.0% | 0.01% | +9.1% |
Q2 2017 | $17,592,000 | -16.4% | 340 | 0.0% | 0.01% | -15.4% |
Q1 2017 | $21,043,000 | +105115.0% | 340 | 0.0% | 0.01% | 0.0% |
Q4 2016 | $20,000 | +42.9% | 340 | 0.0% | 0.01% | +44.4% |
Q2 2016 | $14,000 | +133.3% | 340 | +112.5% | 0.01% | +125.0% |
Q1 2016 | $6,000 | – | 160 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Baker Brothers Advisors | 51,046,060 | $2,892,270,000 | 23.68% |
Lagoda Investment Management, L.P. | 88,615 | $5,021,000 | 8.38% |
Matrix Capital Management Company, LP | 3,141,852 | $178,017,000 | 5.90% |
Opus Point Partners Management, LLC | 19,127 | $1,084,000 | 2.39% |
EMORY UNIVERSITY | 41,539 | $2,354,000 | 1.86% |
Capital International Sarl | 238,100 | $13,491,000 | 1.62% |
Rhenman & Partners Asset Management AB | 242,198 | $13,723,000 | 1.57% |
CAPITAL GUARDIAN TRUST CO | 1,341,050 | $75,984,000 | 1.21% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 42,500 | $1,890,000 | 1.17% |
JGP Global Gestao de Recursos Ltda. | 16,524 | $936,000 | 1.14% |